Design of an Advanced ATRA-ATO Nanotherapeutic Formulation to against Non-Small-Cell Lung Cancer: from In-vitro to In-vivo

Design of an Advanced ATRA-ATO Nanotherapeutic Formulation to against Non-Small-Cell Lung Cancer: from In-vitro to In-vivo

碩士 === 國立交通大學 === 材料科學與工程學系所 === 107

Bibliographic Details
Main Authors:	Yu, Sheng-Chih, 游昇智
Other Authors:	Liu, Dean-Mo
Format:	Others
Language:	en_US
Published:	2019
Online Access:	http://ndltd.ncl.edu.tw/handle/63s475

Similar Items

Recent Advances in Nanotherapeutics for Multiple Myeloma
by: Daniela Iannazzo, et al.
Published: (2020-10-01)

Development of ATRA Parenteral Dosage Form and Improvement of ATRA Oral Capsule: Formulation and Pharmacokinetic Study of ATRA Liposomes
by: WEN-CHANG CHEN, et al.
Published: (2001)

Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics.
by: Rachel A Kudgus, et al.
Published: (2013-01-01)

Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii
by: Ayaz Anwar, et al.
Published: (2019-06-01)

Targeted nanotherapeutics in cancer
by: Shiekh FA
Published: (2014-03-01)

MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
by: Susana Carregal-Romero, et al.
Published: (2020-05-01)

Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
by: Dima Hattab, et al.
Published: (2021-07-01)

Nanotherapeutics in angiogenesis: synthesis and in vivo assessment of drug efficacy and biocompatibility in zebrafish embryos
by: Cheng J, et al.
Published: (2011-09-01)

Reprogramming Cells for Synergistic Combination Therapy with Nanotherapeutics against Uveal Melanoma
by: Paula Milán Rois, et al.
Published: (2018-09-01)

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells
by: Luciana Yamamoto de Almeida, et al.
Published: (2021-09-01)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
by: Nanxia Zhao, et al.
Published: (2020-09-01)

Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease
by: Loredana Leggio, et al.
Published: (2020-09-01)

RNA Nanotherapeutics for the Amelioration of Astroglial Reactivity
by: Jayden A. Smith, et al.
Published: (2018-03-01)

Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension
by: Victor Segura-Ibarra, et al.
Published: (2018-07-01)

Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro
by: Elechalawar CK, et al.
Published: (2020-02-01)

Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease
by: Dhruv R. Seshadri, et al.
Published: (2018-07-01)

ATO/ATRA/anthracycline-chemotherapy sequential consolidation achieves long-term efficacy in primary acute promyelocytic leukemia.
by: Zi-Jie Long, et al.
Published: (2014-01-01)

Nanotherapeutics to Overcome Conventional Cancer Chemotherapy Limitations
by: Moorthi Chidambaram, et al.
Published: (2011-02-01)

Carbon Nanohorns as Effective Nanotherapeutics in Cancer Therapy
by: Manuela Curcio, et al.
Published: (2021-12-01)

Biomaterials and Nanotherapeutics for Enhancing Skin Wound Healing
by: Subhamoy Das, et al.
Published: (2016-10-01)

Vascular targeted nanotherapeutic approach for obesity treatment
by: Sibuyi NRS, et al.
Published: (2018-11-01)

Antitumor Features of Vegetal Protein-Based Nanotherapeutics
by: Silvia Voci, et al.
Published: (2020-01-01)

Engineering Extracellular Vesicles as Nanotherapeutics for Regenerative Medicine
by: Lalithasri Ramasubramanian, et al.
Published: (2019-12-01)

Polymer Nanoparticle Engineering for Podocyte Repair: From in Vitro Models to New Nanotherapeutics in Kidney Diseases
by: Claudio Colombo, et al.
Published: (2017-02-01)

Neutrophils and Macrophages as Targets for Development of Nanotherapeutics in Inflammatory Diseases
by: Yujie Su, et al.
Published: (2020-12-01)

Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation
by: Huize Yan, et al.
Published: (2019-08-01)

Anti-Cancerous Potential of Polyphenol-Loaded Polymeric Nanotherapeutics
by: Umeorah Ernest, et al.
Published: (2018-10-01)

Anti-HIV-1 nanotherapeutics: promises and challenges for the future
by: Mahajan SD, et al.
Published: (2012-10-01)

Nanotherapeutics in the EU: an overview on current state and future directions
by: Hafner A, et al.
Published: (2014-02-01)

Design and development of polymer-based nanotherapeutics for the treatment of cancer
by: Schmid, D.
Published: (2016)

Advances of ATRA combined with arsenic in the treatment of acute promyelocytic leukemia
by: Feng Liu
Published: (2020-07-01)

Bioactive nanotherapeutic trends to combat triple negative breast cancer
by: Pallabita Chowdhury, et al.
Published: (2021-10-01)

Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and Monocultures
by: Issan Zhang, et al.
Published: (2020-11-01)

Nanotherapeutic modulation of excitotoxicity and oxidative stress in acute brain injury
by: Rick Liao, et al.
Published: (2020-11-01)

Glycan-based nanotherapeutics for selective drug delivery in gastric cancer
by: Elisabete Cristina Nunes Fernandes
Published: (2020)

Small molecule analysis of Taiwan cobra (Naja atra) venom
by: Wei-Ting Liu, et al.

Development of a nanoliposomal formulation of erlotinib for lung cancer and in vitro/in vivo antitumoral evaluation
by: Zhou X, et al.
Published: (2017-12-01)

Effects of Resveratrol against Lung Cancer: In Vitro and In Vivo Studies
by: Michael Yousef, et al.
Published: (2017-11-01)

Epigenetic Regulation and Nonepigenetic Mechanisms of Ferroptosis Drive Emerging Nanotherapeutics in Tumor
by: Yue Cheng, et al.
Published: (2021-01-01)

External and Internal Stimuli-Responsive Metallic Nanotherapeutics for Enhanced Anticancer Therapy
by: Adityanarayan Mohapatra, et al.
Published: (2021-01-01)

Cannot write session to /tmp/vufind_sessions/sess_h9svqcso4ji7rkcbrecqa747sv